Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma

In conclusion, the frequency of MDSCs before the treatment is a prognostic factor in HAIC against HCC.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research